Class information for:
Level 2: IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
140 23462 46.5 88%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
140 2             IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY 23462
643 1                   DENDRITIC CELLS//IMMUNOTHERAPY//TUMOR LYSATE 3213
1375 1                   CANCER TESTIS ANTIGEN//NY ESO 1//MAGE 2692
2862 1                   CHIMERIC ANTIGEN RECEPTOR//ADOPTIVE CELL THERAPY//SURG BRANCH 2128
4080 1                   REGULATORY T CELLS//FOXP3//TUMOR INFILTRATING LYMPHOCYTES 1851
7415 1                   MYELOID DERIVED SUPPRESSOR CELLS//MDSC//MYELOID DERIVED SUPPRESSOR CELLS MDSC 1370
7508 1                   TUMOR INFILTRATING LYMPHOCYTES//ADOPTIVE IMMUNOTHERAPY//TIL 1360
7512 1                   GLIOMA//GL261//BRAIN TUMOR PROGRAM 1360
8124 1                   TUMOR VACCINE//GENE THERAPY//B71 1289
10204 1                   ANTIGEN PROCESSING MACHINERY//BIOQUIM BIOL MOL INMUNOL 3//HLA CLASS I 1082
13573 1                   IMMUNOGENIC CELL DEATH//U1015//U805 828
13629 1                   TUMOR IMMUNOL BIOL//SIPULEUCEL T//5T4 823
14101 1                   IDIOTYPE//IDIOTYPE VACCINATION//IDIOTYPE VACCINE 792
15817 1                   PRAME//LEUKEMIA ASSOCIATED ANTIGENS//PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA 690
16780 1                   CANC VACCINE DEV PROGRAM//CANC IMMUNOL IMMUNOTHER Y//TUMOR VACCINE GRP 636
17208 1                   NEWCASTLE DISEASE VIRUS//ACTIVE SPECIFIC IMMUNOTHERAPY ASI//ACTIVE SPECIFIC IMMUNOTHERAPY 611
17426 1                   IRX 2//IMMUNE SUPPRESSOR CELLS//SERV 151Z2 600
20004 1                   CYTOKINE INDUCED KILLER CELLS//CIK CELLS//CIK 481
24733 1                   TUMOR IMMUN TOLERANCE SECT//SV40 T ANTIGEN TRANSGENIC MICE//CCDC134 303
24888 1                   CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE 298
25112 1                   GV1001//PA MSHA VACCINE//HTERTC27 291
25218 1                   ORAL BIOL ORAL MED//CD3 ZETA//ZETA CHAIN 287
26564 1                   RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES 251
33425 1                   ARTIFICIAL ANTIGEN PRESENTING CELLS//ANTIGEN SPECIFIC CD8T CELLS//HLA A2 IG 125
35146 1                   TNFRSF21//ARA267 ALPHA//BIO THER EUT DISCOVERY 101

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 IMMUNOTHERAPY authKW 782121 12% 22% 2765
2 DENDRITIC CELLS authKW 540317 10% 18% 2289
3 CANCER IMMUNOLOGY IMMUNOTHERAPY journal 387761 5% 26% 1139
4 CANCER VACCINE authKW 347776 2% 47% 566
5 MYELOID DERIVED SUPPRESSOR CELLS authKW 296646 1% 67% 341
6 JOURNAL OF IMMUNOTHERAPY journal 272156 3% 35% 594
7 CANCER TESTIS ANTIGEN authKW 262826 1% 74% 274
8 TUMOR INFILTRATING LYMPHOCYTES authKW 260340 2% 52% 384
9 CHIMERIC ANTIGEN RECEPTOR authKW 211759 1% 73% 223
10 ADOPTIVE IMMUNOTHERAPY authKW 194504 1% 48% 310

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 172610 45% 1% 10460
2 Immunology 116239 34% 1% 8049
3 Medicine, Research & Experimental 39733 16% 1% 3793
4 Hematology 12258 8% 1% 1807
5 Biotechnology & Applied Microbiology 3801 7% 0% 1605
6 Cell Biology 2717 8% 0% 1774
7 Cell & Tissue Engineering 1679 1% 1% 204
8 Genetics & Heredity 1534 5% 0% 1135
9 Pathology 1533 3% 0% 703
10 Otorhinolaryngology 332 1% 0% 286

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 SURG BRANCH 149990 1% 33% 348
2 TUMOR IMMUNOL BIOL 124513 1% 44% 216
3 NEW YORK BRANCH 84014 1% 50% 130
4 IMMUNOL 79694 10% 3% 2244
5 U1015 56120 0% 50% 86
6 CANC VACCINE DEV 51178 0% 73% 54
7 CELLULAR GENET UNIT 49562 0% 54% 71
8 CELL GENE THER Y 48671 1% 16% 233
9 LUDWIG CANC 44541 2% 10% 358
10 CLIN ONCOIMMUNOL 38285 0% 49% 60

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 CANCER IMMUNOLOGY IMMUNOTHERAPY 387761 5% 26% 1139
2 JOURNAL OF IMMUNOTHERAPY 272156 3% 35% 594
3 ONCOIMMUNOLOGY 114035 1% 30% 290
4 CANCER IMMUNOLOGY RESEARCH 43608 1% 27% 123
5 CLINICAL CANCER RESEARCH 42209 3% 5% 702
6 JOURNAL OF IMMUNOLOGY 32034 5% 2% 1176
7 INTERNATIONAL JOURNAL OF CANCER 31495 3% 4% 710
8 CANCER RESEARCH 31493 4% 3% 993
9 IMMUNOTHERAPY 30290 1% 18% 130
10 CANCER GENE THERAPY 30046 1% 11% 214

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 IMMUNOTHERAPY 782121 12% 22% 2765 Search IMMUNOTHERAPY Search IMMUNOTHERAPY
2 DENDRITIC CELLS 540317 10% 18% 2289 Search DENDRITIC+CELLS Search DENDRITIC+CELLS
3 CANCER VACCINE 347776 2% 47% 566 Search CANCER+VACCINE Search CANCER+VACCINE
4 MYELOID DERIVED SUPPRESSOR CELLS 296646 1% 67% 341 Search MYELOID+DERIVED+SUPPRESSOR+CELLS Search MYELOID+DERIVED+SUPPRESSOR+CELLS
5 CANCER TESTIS ANTIGEN 262826 1% 74% 274 Search CANCER+TESTIS+ANTIGEN Search CANCER+TESTIS+ANTIGEN
6 TUMOR INFILTRATING LYMPHOCYTES 260340 2% 52% 384 Search TUMOR+INFILTRATING+LYMPHOCYTES Search TUMOR+INFILTRATING+LYMPHOCYTES
7 CHIMERIC ANTIGEN RECEPTOR 211759 1% 73% 223 Search CHIMERIC+ANTIGEN+RECEPTOR Search CHIMERIC+ANTIGEN+RECEPTOR
8 ADOPTIVE IMMUNOTHERAPY 194504 1% 48% 310 Search ADOPTIVE+IMMUNOTHERAPY Search ADOPTIVE+IMMUNOTHERAPY
9 CYTOKINE INDUCED KILLER CELLS 186324 1% 89% 162 Search CYTOKINE+INDUCED+KILLER+CELLS Search CYTOKINE+INDUCED+KILLER+CELLS
10 TUMOR ANTIGEN 181553 1% 45% 311 Search TUMOR+ANTIGEN Search TUMOR+ANTIGEN

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 GALLUZZI, L , SENOVILLA, L , VACCHELLI, E , EGGERMONT, A , FRIDMAN, WH , GALON, J , SAUTES-FRIDMAN, C , TARTOUR, E , ZITVOGEL, L , KROEMER, G , (2012) TRIAL WATCH DENDRITIC CELL-BASED INTERVENTIONS FOR CANCER THERAPY.ONCOIMMUNOLOGY. VOL. 1. ISSUE 7. P. 1111 -1134 271 68% 59
2 GABRILOVICH, DI , NAGARAJ, S , (2009) MYELOID-DERIVED SUPPRESSOR CELLS AS REGULATORS OF THE IMMUNE SYSTEM.NATURE REVIEWS IMMUNOLOGY. VOL. 9. ISSUE 3. P. 162 -174 94 72% 2065
3 KERSHAW, MH , WESTWOOD, JA , DARCY, PK , (2013) GENE-ENGINEERED T CELLS FOR CANCER THERAPY.NATURE REVIEWS CANCER. VOL. 13. ISSUE 8. P. 525-541 158 89% 107
4 DAI, HR , WANG, Y , LU, XC , HAN, WD , (2016) CHIMERIC ANTIGEN RECEPTORS MODIFIED T-CELLS FOR CANCER THERAPY.JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. VOL. 108. ISSUE 7. P. - 132 85% 9
5 RUELLA, M , KALOS, M , (2014) ADOPTIVE IMMUNOTHERAPY FOR CANCER.IMMUNOLOGICAL REVIEWS. VOL. 257. ISSUE 1. P. 14 -38 222 67% 24
6 GABRILOVICH, DI , OSTRAND-ROSENBERG, S , BRONTE, V , (2012) COORDINATED REGULATION OF MYELOID CELLS BY TUMOURS.NATURE REVIEWS IMMUNOLOGY. VOL. 12. ISSUE 4. P. 253 -268 108 55% 826
7 DUDLEY, ME , ROSENBERG, SA , RESTIFO, NP , (2012) ADOPTIVE IMMUNOTHERAPY FOR CANCER: HARNESSING THE T CELL RESPONSE.NATURE REVIEWS IMMUNOLOGY. VOL. 12. ISSUE 4. P. 269 -281 104 70% 480
8 GILL, S , JUNE, CH , (2015) GOING VIRAL: CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR HEMATOLOGICAL MALIGNANCIES.IMMUNOLOGICAL REVIEWS. VOL. 263. ISSUE 1. P. 68 -89 115 71% 74
9 ANURATHAPAN, U , LEEN, AM , BRENNER, MK , VERA, JF , (2014) ENGINEERED T CELLS FOR CANCER TREATMENT.CYTOTHERAPY. VOL. 16. ISSUE 6. P. 713-733 178 83% 11
10 ROSENBERG, SA , RESTIFO, NP , (2015) ADOPTIVE CELL TRANSFER AS PERSONALIZED IMMUNOTHERAPY FOR HUMAN CANCER.SCIENCE. VOL. 348. ISSUE 6230. P. 62 -68 69 78% 203

Classes with closest relation at Level 2


Rank Class id link
1 919 PD L1//PD 1//FOXP3
2 1367 DENDRITIC CELLS//DC SIGN//LANGERHANS CELLS
3 741 ANTIGEN PRESENTATION//IMMUNOLOGY//ANTIGEN PROCESSING
4 328 NK CELLS//NATURAL KILLER CELLS//KIR
5 1321 INTERLEUKIN 12//CD23//INTERLEUKIN 4
6 2020 CELLULAR IMMUNOLOGY//IMMUNOLOGY//EPICUTANEOUS IMMUNIZATION
7 3092 POSTOPERATIVE SEPTIC COMPLICATIONS//TREATMENT RELATED TOXICITIES//MIGRATION STIMULATION FACTOR
8 3775 AH 81//IRIDOLOGY//HLA B8 DR3
9 854 CD40//BAFF//CD40 LIGAND
10 3041 PSK//OK 432//IMEXON

Go to start page